Why Vascular Surgeons Get Sued: The Missed Aneurysm and the Amputation That Came Too Late

By John Mahoney · June 2026 · 9 min read

Vascular surgery is unusual among the surgical specialties: the lawsuit that ends a career here often is not about the operation at all. It is about the clock. By the time a vascular surgeon's care is questioned, the most damaging allegation is frequently that an aortic aneurysm was missed, a dissection was called something else, or a limb was lost because revascularization came hours too late. In a field where the difference between a save and a catastrophe is measured in time-to-treatment, delay is the central thread running through nearly every serious claim — and it is what makes this specialty both high-frequency and high-severity at once.

This article is written for plaintiff and defense med-mal attorneys screening vascular cases. It covers the frequency-and-severity profile, the allegation mix, the cannot-miss conditions, the protocol and documentation factors that drive payment, and what separates a strong case from a weak one.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The figures below are drawn from closed-claims reviews and verdict databases across different jurisdictions and eras (including some non-U.S. data noted below); treat them as directional, and verify the medicine and the law in the controlling jurisdiction.

The Frequency-and-Severity Reality

Vascular surgery sits in the high-risk surgical band. The closest Jena (NEJM 2011) benchmarks are thoracic-cardiovascular surgery at 18.9% per year and general surgery at 15.3% — both far above the roughly 5% rate of the low-risk specialties. Specialty-specific data sharpens the picture: a Journal of Vascular Surgery prevalence study reported that 18.5% of practicing vascular surgeons were named in a malpractice suit within a two-year window, and cumulative career risk in high-risk specialties approaches near-certainty.

Severity is high and the paid cases are large. In a review of U.S. plaintiff-verdict cases (Westlaw), the median award was $750,000 and the mean was $1,830,000, with cases running roughly 4.8 years from incident to verdict. The defense prevailed in about 65% of tried cases and plaintiffs in about 23%, with roughly 12% settling — so most tried cases are defensible, but the ones that are not carry seven-figure exposure. The injury mix explains the dollars: death accounts for roughly 31.9% and major amputation roughly 23.7% of the adverse events driving claims, keeping per-paid-claim severity well above the all-specialty average. (In the UK/NHS system, reportedly 74% of vascular claims resulted in payment, with lower-limb amputation the single highest-cost injury cluster — a non-U.S. figure, but a consistent signal about where the money is.)

The Dominant Allegation Types

Unlike most surgical fields, where technique allegations lead, vascular surgery's top category is diagnostic. From the U.S. closed-case review, the allegation mix is:

• Failure or delay to diagnose and treat — the top category at roughly 48.9% of cases (about 16.9% error/delay in diagnosis plus about 18.8% failure to treat). Nearly half of all vascular claims are, at their core, timing claims.
• Complication of open surgery / post-operative complications — roughly 31.9%.
• Negligent procedure / procedural error — roughly 25.2%.
• Failure to warn / inadequate informed consent — a recurrent secondary driver, especially prominent in UK/NHS cohorts.
• Negligent post-operative care and monitoring.

For screening, this is the defining feature: vascular surgery behaves like a cognitive specialty wearing a surgeon's coat. The largest single bucket is a missed or delayed diagnosis, and the medicine at issue is often whether the right imaging was ordered and acted on in time — not whether the suture line held.

The "Cannot-Miss" Conditions That Drive the Claims

A short list of time-critical conditions accounts for most of the serious exposure. These should function as a triage checklist on any vascular intake:

• Aortic aneurysm and aortic dissection — the headline misses. Roughly 83% of aortic litigation involves wrongful-death suits, and these catastrophes are commonly misattributed at first presentation to gastrointestinal (about 12%), cardiac (about 9%), or musculoskeletal (about 9%) causes. The chest, back, or abdominal pain that was called something benign is the recurring fact pattern.
• Acute and critical limb ischemia — roughly 14.8% of cases. Delay is the enemy; the longer revascularization waits, the more likely a major amputation becomes.
• Carotid interventions — roughly 11.85% of cases, driven by peri-procedural stroke and neurovascular injury.
• Vascular trauma — roughly 9.6%, including bleeding, a missed arterial injury, and compartment syndrome.
• Dialysis access (roughly 8.2%) and venous surgery (roughly 5.9%).

The adverse events these conditions produce are, in order, death (about 31.9%), major amputation (about 23.7%), neurovascular injury (about 14.8%), and bleeding (about 5.9%). The unifying theme is that almost every one of them is a race against time, and the claim usually alleges the race was lost.

Contributing Factors: Protocol, Documentation, and the Clock

The contributing-factor data points squarely at systems and records rather than raw surgical skill — which is exactly why these cases are so winnable or losable on the chart:

• Failure to have or follow a policy or protocol — reportedly the single largest amplifier of paid claims, present in about 63% of indemnity-paid vascular surgical claims (The Doctors Company). When a time-critical presentation has a protocolized pathway and the pathway was not followed, the defense loses its best argument.
• Weak or absent documentation — present in about 56% of paid claims. In a timing case, the chart that shows when imaging was ordered, when results returned, and when the surgeon was notified is the whole ballgame.
• Clinical judgment and inadequate patient assessment — about 47% of indemnity-paid surgical claims.
• Communication failures — provider-to-patient and provider-to-provider, including handoffs and the follow-up of abnormal imaging.
• Informed-consent deficiencies — a leading secondary allegation, prominent in the UK/NHS cohorts.
• Time-to-treatment delay — the central thread tying together the delayed-diagnosis and amputation claims.

Note what is not at the top of this list: pure technical skill. Closed-claims analysis frames the causes here as multifactorial and rarely attributable to technique alone. That makes documentation and protocol adherence the decisive defensibility levers. A complete chart that proves the protocol was followed and the clock was respected defends a bad outcome; a thin chart in a 63%-protocol-failure / 56%-documentation-gap field hands the plaintiff the case.

What Separates a Strong Case From a Weak One

Because vascular litigation is dominated by timing, the strong-versus-weak analysis is unusually concrete — and useful to both sides.

Strong case (plaintiff-favorable)

• A missed or delayed aortic aneurysm or dissection, where the presenting pain was attributed to a GI, cardiac, or musculoskeletal cause and the indicated imaging (CT angiography) was not ordered or not acted on.
• An acute limb ischemia case where the chart shows a documented delay between presentation and revascularization, and the amputation followed the delay.
• A case where a time-critical protocol existed and was not followed — the 63% amplifier — with the deviation visible in the record.
• A documentation gap that obscures when imaging was ordered, when results returned, or when the surgeon was notified, in a presentation where minutes mattered.
• A peri-procedural stroke after a carotid intervention where the consent never disclosed that recognized risk.

Weak case (defense-favorable)

• A known, disclosed complication of an indicated procedure — stroke after carotid intervention, bleeding, reintervention — named in a thorough, contemporaneous consent.
• A record that proves the protocol was followed and the clock was respected: prompt imaging, timely escalation, documented decision-making.
• A bad outcome from a genuinely emergent, unsalvageable presentation where the standard of care was met and the timeline is fully documented.
• A complete chart showing closed-loop follow-up of abnormal imaging and structured handoffs.

For both sides, the controlling inquiry is the same: was the diagnosis and treatment timely, was the governing protocol followed, and does the chart prove the timeline? A defensible vascular case is one where the record answers all three; a payable one is where the clock ran out and the chart cannot explain why. Two free tools are particularly suited to these cases: the causation chain builder, to test whether a documented delay actually caused the amputation or death rather than an unsalvageable underlying condition, and the Daubert and FRE 702 workup, because "the delay changed the outcome" is a causation opinion the other side will move to exclude.

The Damages Question

Vascular damages run high because the injuries are catastrophic — death in roughly a third of claim-driving events and major amputation in nearly a quarter, with a reported mean plaintiff verdict near $1.83 million. Amputation cases in particular combine lifelong functional loss, prosthetic and care costs, and substantial non-economic damages. As always, the recoverable figure depends heavily on the jurisdiction's caps, comparative-fault rules, and wrongful-death framework, so the state matters as much as the injury. The medical malpractice damages calculator is a fast way to bracket the recoverable range before committing to a case.

Bottom Line

Vascular surgery is sued often and, when it pays, pays large — because the harms are death and amputation and the dominant allegation is that a time-critical diagnosis or treatment came too late. Nearly half of claims are failure-to-diagnose-and-treat cases, protocol failures amplify roughly 63% of paid claims, and weak documentation appears in about 56% of them. For plaintiff and defense attorneys alike, the case lives or dies on one question: was the care timely, was the protocol followed, and does the chart prove it?

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →